iSTAR Medical logo.png
iSTAR Medical Expands Commercial Rollout of MINIject with First Surgeries in Sweden and Norway
December 01, 2022 03:00 ET | iSTAR Medical
For immediate release iSTAR Medical Expands Commercial Rollout of MINIject with First Surgeries in Sweden and Norway The only commercially available MIGS device currently targeting the supraciliary...
Investigational Optejet® Microdose Dispenser from Eyenovia Shows Promise in Improving Treatment for Myopia, Presbyopia and Patients Getting Eye Exams
October 17, 2022 09:01 ET | Eyenovia
NEW YORK, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Two recent studies show that the novel Optejet® dispenser from Eyenovia, Inc., an ophthalmic pharmaceutical technology company, may be a more...
Eyenovia Chairman Dr. Sean Ianchulev: The Making Of An iDoctor - Immigrant, Innovator, Inventor
September 21, 2022 10:01 ET | Eyenovia
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Before founding Eyenovia, Dr. Sean Ianchulev had established himself as a pioneer and innovator in the field of ophthalmology. Inspired by his mother, a...
22157.jpg
Global Glaucoma Treatment Market Report 2022: Continuous Drug Innovations Presents Opportunities
September 20, 2022 05:18 ET | Research and Markets
Dublin, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Glaucoma treatment Market Research and Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global glaucoma...
Logo.png
Rich Insights into the Glaucoma Clinical Trial Analysis Featuring 70+ Companies and Therapies | DelveInsight
September 12, 2022 13:00 ET | DelveInsight Business Research LLP
New York, USA, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Rich Insights into the Glaucoma Clinical Trial Analysis Featuring 70+ Companies and Therapies | DelveInsight The number of clinical trials in...
Eyenovia's Novel Optejet® Dispenser Puts People's Eyes First
August 30, 2022 09:01 ET | Eyenovia
NEW YORK, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP™) therapeutics, brings...
Iantrek logo and byline tight.jpg
Iantrek Raises $23M Series B Financing to Advance Next Generation Ophthalmic Micro-Interventional Technologies
August 30, 2022 08:00 ET | Iantrek, Inc.
WHITE PLAINS, N.Y., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Iantrek, Inc., a medical device company founded by ophthalmic innovator Dr. Sean Ianchulev, announced the closing of a $23M Series B financing....
Optometry Equipment Market Report 2022: Rising Government Initiatives to Control Visual Impairment Fueling Growth
August 30, 2022 05:18 ET | Research and Markets
Dublin, Aug. 30, 2022 (GLOBE NEWSWIRE) -- The "Optometry Equipment Market by Type (OCT, Ophthalmoscope, Autorefractor, Tonometer, Slitlamps, Wavefront Analyzer), Application(General Examination,...
Sight Sciences Introduces the SION™ Surgical Instrument – The First Bladeless Device Used in Goniotomy
August 23, 2022 08:03 ET | Sight Sciences, Inc.
MENLO PARK, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative solutions intended to...
SightSciences_Logo_2C_RGB.png
Sight Sciences Announces Long-Term Safety and Effectiveness Data of Standalone Use of the OMNI® Surgical System in Patients with Open Angle Glaucoma
August 16, 2022 08:01 ET | Sight Sciences, Inc.
MENLO PARK, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative solutions intended to...